Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India

AP Pack, J Sastry, EE Tolley, S Kaaya, J Headley… - AIDS care, 2019 - Taylor & Francis
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …
被引用次数：3 相关文章

Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India.

AP Pack, J Sastry, EE Tolley, S Kaaya, J Headley… - AIDS Care, 2018 - europepmc.org
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …

Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India

AP Pack, J Sastry, EE Tolley… - … Aspects of AIDS …, 2019 - scholars.northwestern.edu
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …

Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India.

AP Pack, J Sastry, EE Tolley, S Kaaya, J Headley… - 2019 - cabidigitallibrary.org
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …
[PDF] google.com

[PDF][PDF] Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India

AP Pack, J Sastry, EE Tolley, S Kaaya, J Headley… - AIDS care, 2019 - drive.google.com
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …

Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India

AP Pack, J Sastry, EE Tolley, S Kaaya, J Headley… - AIDS …, 2019 - ingentaconnect.com
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …

Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India

AP Pack, J Sastry, EE Tolley, S Kaaya… - … and Socio-Medical …, 2019 - research.monash.edu
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …

Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India

AP Pack, J Sastry, EE Tolley, S Kaaya… - AIDS …, 2019 - pubmed.ncbi.nlm.nih.gov
Researchers and advocates have increasingly called for adolescent participation in clinical
trials for new HIV prevention products, particularly adolescent girls in areas most affected by …